Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
What is the ideal interval to wait after surgery before starting external beam PBI treatment?
Answer from: Radiation Oncologist at Community Practice
I typically wait 2-3 weeks to simulate and start anywhere from 3-5 weeks post-surgery as long as they are well healed.
Comments
Radiation Oncologist at BASS Cancer Center
Thank you!
7562
Sign In
or
Register
to read more
15091
Related Questions
Is DCISionRT appropriate for multifocal DCIS?
Does radiation therapy (ex. to the breast) in patients with CDK4 mutations increase the risk of developing melanoma?
Would you recommend PMRT to a clinically node positive (biopsy proven axillary node and indeterminate single IMN node) BRCA positive patient with multiple medical co-morbidities including scleroderma and ILD who is treated with neoadjuvant chemotherapy (NAC) and mastectomy who converts to ypT0/ypN0?
In which patients do you utilize a breast MRI as part of the initial workup for breast cancer?
Would you consider whole breast re-irradiation in a patient with a second/recurrent breast cancer and prior history of breast radiation therapy many years ago, if the tumor characteristics are not amenable to partial breast re-irradiation?
Would you consider RNI alone without CW for an isolated nodal recurrence after treatment with mastectomy and SNB for an early-stage breast cancer with no prior RT?
Is there additional concern for late cardiac toxicity when using ultrahypofractionated breast radiation protocols, given that the BED to the heart is higher?
What are your top takeaways in Radiation Oncology from SABCS 2024?
When using surface image-guidance for breast radiation, how do you accommodate for changes in anatomy?
Would you offer ultrahypofractionated 5-fraction whole breast only for a women with ER-/HER2+/cN+ disease with pCR following neoadjuvant systemic therapy?
Thank you!